SIGLEC1 and neoplasm: Consistent with this finding, we observed that Abraxane increased tumor infiltration of CD45+ hematopoietic cells and CD11b+CD169+ macrophages in the MDA-MB435 tumors compared to untreated tumors and αCSF-1-treated tumors.